STOCK TITAN
  1. Home
  2. Sec-filings
  3. PCSA
  4. [8-K] Processa Pharmaceuticals, Inc. Common Reports Material Event

[8-K] Processa Pharmaceuticals, Inc. Common Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock PCSA logo
Processa Pharmaceuticals Inc

NASDAQ:PCSA

PCSA Rankings

#11236 Ranked by Market Cap
N/A Ranked by Dividends

PCSA Latest News

Jul 1, 2025
Processa Pharmaceuticals Provides Portfolio and Business Update
Jun 17, 2025
Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering
Jun 17, 2025
Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate
Jun 13, 2025
Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025
May 30, 2025
Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting

PCSA Latest SEC Filings

Jul 15, 2025
[8-K] Processa Pharmaceuticals, Inc. Common Reports Material Event
Jul 1, 2025
[8-K] Processa Pharmaceuticals, Inc. Common Reports Material Event
Jun 30, 2025
[8-K] Processa Pharmaceuticals, Inc. Common Reports Material Event
Jun 24, 2025
[SCHEDULE 13G] Processa Pharmaceuticals, Inc. Common SEC Filing
Jun 23, 2025
[SCHEDULE 13G] Processa Pharmaceuticals, Inc. Common SEC Filing

PCSA Stock Data

6.02M
23.15M
5.71%
2.09%
2.81%
Biotechnology
Pharmaceutical Preparations
Link
United States
HANOVER